Ellias Helen K.
SAB Biotherapeutics, Inc. · Director
Ellias Helen K. is listed in public filings as director. This Ellias Helen K. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include SAB Biotherapeutics, Inc. (SABS). Investors use Ellias Helen K.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $599k150k shares | Grant / ExerciseDec 16, 2025 | $598.5K150k shares | $3.99 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $136k35k shares | Grant / ExerciseNov 1, 2024 | $135.8K35k shares | $3.88 | -- | |
| $78k20k shares | Grant / ExerciseNov 1, 2024 | $77.6K20k shares | $3.88 | -- |